All News #Library
Rare Diseases
Orvida Pharma Announces KM-023 Phase 1a Success, Starts Phase 1b
15 Apr 2026 //
GLOBENEWSWIRE
Kamari Pharma closes $23M financing for rare skin disease drug
03 Jun 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support